Autonomics Flashcards
(360 cards)
- Atropine is used to counteract:
a) High sympathetic activity
b) Excessively high parasympathetic activity
c) Muscle contractions
d) Neurotransmitter depletion
b) Excessively high parasympathetic activity
Rationale: Atropine is administered when parasympathetic activity is excessively high, such as in severe bradycardia, by blocking muscarinic receptors.
- Nicotinic receptors are primarily located in:
a) The heart
b) Smooth muscles
c) Autonomic ganglia of the ANS and NMJ
d) The liver
c) Autonomic ganglia of the ANS and NMJ
Rationale: Nicotinic receptors are located in the autonomic ganglia of the ANS, neuromuscular junctions (NMJ), and adrenal medulla.
- The action of muscarinic receptors in the heart is primarily:
a) Excitatory
b) Inhibitory
c) Neutral
d) Variable
b) Inhibitory
Rationale: In the heart, muscarinic receptors have an inhibitory effect, but they are excitatory in smooth muscle and glands.
- Ganglionic blockers such as hexamethonium act by blocking:
a) Muscarinic receptors
b) Nicotinic receptors
c) Beta receptors
d) Alpha receptors
b) Nicotinic receptors
Rationale: Ganglionic blockers like hexamethonium block nicotinic receptors, particularly at autonomic ganglia.
- Atropine’s mechanism of action involves:
a) Exciting muscarinic receptors
b) Blocking muscarinic receptors
c) Increasing neurotransmitter release
d) Blocking nicotinic receptors
b) Blocking muscarinic receptors
Rationale: Atropine acts by blocking muscarinic receptors, thus reducing parasympathetic activity.
- In smooth muscles and glands, muscarinic receptors cause:
a) Inhibition
b) Excitation
c) No change in activity
d) Stabilization
b) Excitation
Rationale: Muscarinic receptors are inhibitory in the heart but excitatory in smooth muscles and glands.
- The effect of activating nicotinic receptors at the NMJ is:
a) Relaxation
b) Excitation
c) Inhibition
d) Stabilization
b) Excitation
Rationale: Nicotinic receptors at the NMJ and in autonomic ganglia primarily cause excitation.
- Atropine is contraindicated in patients with:
a) Low heart rate
b) High heart rate
c) Closed-angle glaucoma
d) Open-angle glaucoma
c) Closed-angle glaucoma
Rationale: Atropine is contraindicated in closed-angle glaucoma due to the risk of increasing intraocular pressure.
- In the SA node, muscarinic receptors’ action leads to:
a) Opening of sodium channels
b) Inhibition of adenylate cyclase and opening of potassium channels
c) Activation of calcium channels
d) Excitation of the heart muscle
b) Inhibition of adenylate cyclase and opening of potassium channels
Rationale: Muscarinic receptors in the SA node inhibit adenylate cyclase, leading to the opening of potassium channels.
- The role of acetylcholine in the cholinergic system is to:
a) Inhibit muscle contraction
b) Act as a neurotransmitter
c) Block receptor activity
d) Decrease heart rate
b) Act as a neurotransmitter
Rationale: Acetylcholine is the primary neurotransmitter in the cholinergic system, playing a crucial role in various physiological functions.
- Hexamethonium’s primary action in the cholinergic system is to:
a) Increase acetylcholine release
b) Block nicotinic receptors at autonomic ganglia
c) Stimulate muscarinic receptors
d) Increase heart rate
b) Block nicotinic receptors at autonomic ganglia
Rationale: Hexamethonium acts as a ganglionic blocker by blocking nicotinic receptors at autonomic ganglia.
- In the treatment of bradycardia, atropine is effective because it:
a) Decreases heart rate further
b) Increases heart rate
c) Has no effect on heart rate
d) Stabilizes heart rate
b) Increases heart rate
Rationale: Atropine is used in severe bradycardia to increase heart rate by reducing parasympathetic activity.
- Muscarinic receptors in smooth muscles and glands are activated to cause:
a) Decreased intracellular calcium
b) Increased intracellular IP3 and calcium
c) Stabilization of membrane potential
d) Decrease in glandular secretions
b) Increased intracellular IP3 and calcium
Rationale: Activation of muscarinic receptors in smooth muscles and glands leads to increased IP3 and intracellular calcium levels.
- The primary effect of nicotinic receptors activation at the adrenal medulla is:
a) Decreased adrenaline release
b) Increased adrenaline release
c) No effect on adrenaline release
d) Stabilization of adrenaline levels
b) Increased adrenaline release
Rationale: Activation of nicotinic receptors at the adrenal medulla typically leads to increased adrenaline release.
- Atropine’s ability to increase sympathetic features is due to its action of:
a) Stimulating muscarinic receptors
b) Blocking muscarinic receptors
c) Activating nicotinic receptors
d) Inhibiting acetylcholine synthesis
b) Blocking muscarinic receptors
Rationale: Atropine increases sympathetic features by blocking muscarinic receptors, reducing parasympathetic activity.
- The use of hexamethonium in the cholinergic system primarily results in:
a) Decreased sympathetic activity
b) Increased parasympathetic activity
c) Reduced neurotransmitter release
d) Enhanced neurotransmitter release
c) Reduced neurotransmitter release
Rationale: Hexamethonium reduces neurotransmitter release by blocking nicotinic receptors at autonomic ganglia.
- In glaucoma treatment, the role of cholinergic drugs like Pilocarpine is to:
a) Decrease intraocular pressure
b) Increase intraocular pressure
c) Dilate the pupil
d) Improve vision clarity
a) Decrease intraocular pressure
Rationale: Cholinergic drugs like Pilocarpine decrease intraocular pressure by enhancing the drainage of aqueous humor.
- Atropine’s use in severe bradycardia works by:
a) Decreasing cardiac output
b) Increasing cardiac output
c) Stabilizing heart rate
d) Decreasing heart rate
b) Increasing cardiac output
Rationale: Atropine is used in severe bradycardia to increase heart rate and cardiac output by reducing parasympathetic activity.
- The action of muscarinic receptors in the heart primarily results in:
a) Increased heart rate
b) Decreased heart rate
c) No change in heart rate
d) Irregular heart rhythm
b) Decreased heart rate
Rationale: Muscarinic receptors in the heart primarily have an inhibitory effect, leading to a decreased heart rate.
- The therapeutic action of acetylcholine in the cholinergic system includes:
a) Contracting smooth muscles
b) Relaxing smooth muscles
c) Blocking neurotransmitter release
d) Increasing blood pressure
a) Contracting smooth muscles
Rationale: Acetylcholine in the cholinergic system plays a role in contracting smooth muscles, among other functions.
- What is the primary neurotransmitter of the parasympathetic nervous system?
a) Dopamine
b) Serotonin
c) Acetylcholine
d) Norepinephrine
c) Acetylcholine
Rationale: Acetylcholine is the primary neurotransmitter of the parasympathetic nervous system, responsible for stimulating parasympathetic activities.
- Which type of drug would likely decrease heart rate?
a) Cholinergic Agonist
b) Cholinergic Antagonist
c) Adrenergic Agonist
d) Adrenergic Antagonist
a) Cholinergic Agonist
Rationale: Cholinergic agonists stimulate parasympathetic activity, leading to effects like decreased heart rate.
- Which drug category is known to dilate pupils?
a) Cholinergic Agonist
b) Cholinergic Antagonist
c) Adrenergic Agonist
d) Adrenergic Antagonist
c) Adrenergic Agonist
- Which medication type is used to manage asthma by expanding airways?
a) Cholinergic Agonist
b) Cholinergic Antagonist
c) Adrenergic Agonist
d) Adrenergic Antagonist
c) Adrenergic Agonist
Rationale: Adrenergic agonists increase sympathetic responses, such as expanded airways, useful in asthma management.